(Q46143187)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24571864%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

title

Lyme disease: neurology, neurobiology, and behavior (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24571864%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24571864%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

author name string

John J Halperin

series ordinal

1

1 reference

http://europepmc.org/abstract/MED/24571864

19 December 2017

language of work or name

English

0 references

publication date

25 February 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24571864%20AND%20SRC:MED&resulttype=core&format=json

Clinical Infectious Diseases

8 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24571864%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

volume

58

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24571864%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24571864%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

page(s)

1267-1272

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24571864%20AND%20SRC:MED&resulttype=core&format=json

The chemokine CXCL13 is a key regulator of B cell recruitment to the cerebrospinal fluid in acute Lyme neuroborreliosis.

8 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU106

Lyme neuroborreliosis: central nervous system manifestations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU106

Central nervous system abnormalities in Lyme neuroborreliosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU106

Cognitive functioning in late Lyme borreliosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU106

Neuroactive kynurenines in Lyme borreliosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU106

The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU106

Two Controlled Trials of Antibiotic Treatment in Patients with Persistent Symptoms and a History of Lyme Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU106

Evidence-based guidelines for the management of Lyme disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU106

Study and treatment of post Lyme disease (STOP-LD): a randomized double masked clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU106

A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU106

Long-term Outcomes of Persons With Lyme Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU106

Long-term clinical outcome after Lyme neuroborreliosis in childhood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU106

Long-term follow-up of patients with culture-confirmed Lyme disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU106

Long-term outcome of Lyme disease in children given early treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU106

Musculoskeletal and Neurologic Outcomes in Patients with Previously Treated Lyme Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU106

Long-term neuropsychologic and health outcomes of children with facial nerve palsy attributable to Lyme disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU106

Chronic fatigue: symptom and syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU106

Self-reported health status of the general adult U.S. population as assessed by the EQ-5D and Health Utilities Index.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU106

Anti-neural antibody reactivity in patients with a history of Lyme borreliosis and persistent symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU106

Increased IFNα activity and differential antibody response in patients with a history of Lyme disease and persistent cognitive deficits

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU106

Spirochete antigens persist near cartilage after murine Lyme borreliosis therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU106

Non-viable Borrelia burgdorferi induce inflammatory mediators and apoptosis in human oligodendrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU106

The Response of Symptomatic Neurosyphilis to High-Dose Intravenous Penicillin G in Patients with Human Immunodeficiency Virus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU106

Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU106

The consequences of overdiagnosis and overtreatment of Lyme disease: an observational study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU106